Biomarkers for cancer -- often reported with great publicity -- routinely fail to be of clinical use, a Canadian researcher said.Clearly the best "biomarker" is fitness.
Despite large investments and investigation by competent researchers, no new major cancer biomarkers have been approved for clinical use in the past quarter-century, according to Eleftherios Diamandis, MD, PhD, of Mount Sinai Hospital in Toronto.
In a commentary published online in the Journal of the National Cancer Institute, Diamandis said that's because a range of common analytical errors lead to what he called "false discovery," even when reports undergo detailed peer review and appear in high-profile journals.
Do yourself a favor and don't rely on the hype.
Rely on what works.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.